Detailed Narrative
Developing Hospitals Outperform Matured Units
The developing hospitals segment, comprising Lucknow and Patna, has become a significant growth engine, reporting an EBITDA margin of ~33.8% compared to 25% for matured hospitals. This outperformance is driven by high occupancy (64%) and rapid scaling of complex procedures like robotic surgery in Lucknow. Management noted that while ARPOB in these units (₹52,502) is lower than matured units (₹67,303), it is primarily due to the payor mix and they are actively working to reduce the Average Length of Stay (ALOS) to improve realizations.
Aggressive Capacity Expansion Pipeline
Medanta is entering a high-growth phase with 1,000 beds planned for addition over the next two years. The 550-bed Noida facility is on track to be operational by Summer 2025, and a new 110-bed facility in Ranchi was recently approved to alleviate capacity constraints at the existing unit. Furthermore, the company has a long-term pipeline of 1,600 beds across Mumbai Oshiwara, Pitampura, and South Delhi, supported by a ₹3,000 crore capex plan over 3-4 years.
International Patient Dynamics and Bangladesh Headwinds
International patient revenue grew 14% YoY to ₹54.1 crores, now making up 6% of total group revenue. Management acknowledged that while the traditional flow from Bangladesh has been hampered by local turmoil, they are successfully diversifying into African and CIS markets. They expect the upcoming Noida facility to become a major hub for international patients due to its strategic location.
Operational Efficiency and Payor Mix Strategy
The group's ARPOB growth was a modest 1.3%, impacted by a higher proportion of scheme and PPP patients in Patna and Lucknow. However, management emphasized that realization per patient remains healthy and the focus is on volume-led growth. They have not taken a tariff increase in Lucknow for five years or Patna for three years, suggesting significant latent pricing power that could be exercised in the future.
Navigating Regulatory and Legal Hurdles
Expansion is not without challenges; the Indore project remains stalled due to subjudice legal matters, and the South Delhi project has faced multiple stoppages due to pollution-related construction bans in the NCR region. Management is exploring alternative options for Indore while remaining committed to the site if legal issues resolve. In South Delhi, soil testing has commenced, signaling a move toward active construction.